LEERINK PARTNERS UK
LIVE

Serial Number

99319270

Owner

Leerink Intermediate Holdings LLC

Attorney

Cynthia J Walden

Filing Date

Aug 4, 2025

Add to watchlist:

No watchlists yet
View on USPTO

LEERINK PARTNERS UK Trademark

Serial Number: 99319270

LEERINK PARTNERS UK is a trademark filed by Leerink Intermediate Holdings LLC on August 4, 2025. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Leerink Intermediate Holdings LLC

53 State Street
Boston, MA 02109

Entity Type: 16

Trademark Details

Filing Date

August 4, 2025

Registration Date

Not Registered

Published for Opposition

May 26, 2026

Goods & Services

Business consulting; acquisition and merger consultation; providing trade information; compiling financial, securities, stock exchange, trade and quote, index value and other financial market information for business purposes; business intermediary services relating to the matching of potential investors with corporations and entrepreneurs needing funding; business consultation services, namely, business evaluation regarding firms in the biotechnology and health fields for the assessment of the non-financial business value of medical technology

Providing online non-downloadable content, namely, reports and articles in the fields of financial matters and business consulting; Providing non-downloadable instructional videos and podcasts in the field of finance via a website; Providing online non-downloadable content, namely, reports and articles in the fields of financial matters, financial trading, investments, raising capital and capital structure, mergers and acquisitions, debt, and private and public equity; Arranging and conducting conferences and events for educational purposes in the field of finance

Financial consulting; Investment banking services; Financial consulting and advising in the field of mergers and acquisitions; Financial consulting and advising in the field of private and public equity; Financial asset management; Investment advisory and fund management services, and investment consultation; Financial services, namely, operation, administration, and management of private equity funds, venture capital funds, hedge funds, capital investment funds and collective investment vehicles, and raising equity capital for others; Business brokerage services and related consulting pertaining to business sales, mergers, acquisitions and business valuations; Financial services, namely, investment advice, investment management, investment consultation, and investment of funds for others, including private and public equity and debt investment services; Financial services, namely consulting and advising in the field of raising capital and capital structure; Financial services, namely consulting and advising in the field of debt and equity placement transactions; Financial research and equity research brokerage services; Information, advisory, consultancy and financial research services relating to finance and investments; Trading of stocks, equity, securities, and securities index futures; Trade underwriting, structuring, and restructuring, namely, financial services in the nature of securities underwriting and financial consultation in the field of capital structure and restructuring; Financial services, namely, the trading of financial instruments, securities, shares, options and other derivative products; Providing financial services with respect to securities and other financial instruments and products, namely, trading of and investments in securities and financial instruments and products for others; Providing an internet website portal featuring information in the field of finance and in the finance fields of financial, banking, and investment transactions, and payment processing services; Providing information in the field of finance and in the finance fields of financial stock and equity markets, mergers and acquisitions, debt, private and public equity, and capital structure and investments; financial evaluation regarding firms in the biotechnology and health fields for the assessment of the financial value of medical technology

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 21, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 26, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 26, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 20, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 27, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 27, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 27, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 27, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 27, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 1, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 30, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 30, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 29, 2025 GNRN
NON-FINAL ACTION E-MAILED
Dec 29, 2025 GNRT
NON-FINAL ACTION WRITTEN
Dec 29, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 18, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 12, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Aug 4, 2025 MAFR
NEW APPLICATION ENTERED
Aug 4, 2025 NWAP